title: Survival of renal allografted dogs after limited therapy with cyclosporine and the PAF antagonist WEB 2170.
authors.affiliation: Department of Surgery, Addenbrooke's Hospital, Cambridge, England.
authors.forename: S M
authors.initials: SM
authors.lastname: Metcalfe
authors.forename: C J
authors.initials: CJ
authors.lastname: Watson
authors.forename: D G
authors.initials: DG
authors.lastname: Collier
authors.forename: M
authors.initials: M
authors.lastname: DaCosta
authors.forename: P J
authors.initials: PJ
authors.lastname: Friend
authors.forename: S G
authors.initials: SG
authors.lastname: Pollard
authors.forename: R
authors.initials: R
authors.lastname: Luddington
authors.forename: R Y
authors.initials: RY
authors.lastname: Calne
mesh_terms: D000818:Animals; D001381:Azepines / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006085:Graft Survival; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D001381:Azepines; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D010972:Platelet Activating Factor; D014230:Triazoles; C063964:bepafant